Fintel reports that on January 21, 2025, UBS initiated coverage of NeuroPace (NasdaqGM:NPCE) with a Buy recommendation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback